MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Sleep disorders in Parkinson’s disease patients. A case-control study.

    L. Rotaru, M. Cebuc, A. Lupușor, O. Grosu, S. Odobescu, O. Gavriliuc, I. Moldovanu (Chisinau, Republic of Moldova)

    Objective: To determine the quality of sleep, the type of sleep disorders and their correlations with motor impairment in Parkinson's disease (PD) patients. Background: Sleep…
  • 2023 International Congress

    The effect of exercise training on motor and non-motor symptoms in people with Essential Tremor; a feasibility pilot study

    H. Khalil, M. Nazzal, A. Al-Sharman, L. Samman, D. Al-Shorafat, K. El-Salem, H. Al Refa’I, S. Obeidat (Doha, Qatar)

    Objective: To examine the potential benefits of an exercise program on motor and non-motor symptoms in people with Essential Tremor (ET) Background: Besides tremor, patients…
  • 2023 International Congress

    Caregiver burden in Parkinson disease: an updated scoping review

    J. Corcoran, W. Aamodt, S. Seshadri, M. Mirham, A. Job, S. Lettenberger, B. Kluger (Rochester, USA)

    Objective: We performed a scoping review to describe caregiver burden in Parkinson disease (PD) and build on the evidence provided by Mosely at al. [1]…
  • 2023 International Congress

    Very high frequency of early-onset Parkinson’s disease with homozygous PRKN exon 3 deletion amongst indigenous populations in Sabah, Malaysia

    YW. Tay, JCE. Ooi, SY. Lim, YK. Chia, A. Sukri, TS. Toh, JL. Lim, AH. Tan, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

    Objective: We aimed to investigate the frequency of EOPD and PRKN mutations in our diverse Malaysian indigenous populations, who are extremely under-represented in PD genetics…
  • 2023 International Congress

    Transcranial magnetic stimulation study in primary dystonia of presumed genetic etiology

    D. Dhar, A. Bhattacharya, N. Kamble, V. Holla, R. Yadav, B. Muthusamy, P. Pal (Bengaluru, India)

    Objective: To study the neurophysiological parameters in primary dystonia of presumed genetic etiology using transcranial magnetic stimulation (TMS) and correlate with their genotype. Background: The…
  • 2023 International Congress

    Emerging treatments targeting DNA and RNA in Huntington’s disease: a review of future perspectives and current challenges

    G. Lima, F. Sarmento, I. Camargo, R. Saba, S. Silva, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To review the progress made towards the development of a huntingtin (HTT) lowering strategy based on RNA and DNA and also to assess the…
  • 2023 International Congress

    Associations between non-motor symptoms and patient characteristics in Parkinson’s disease: A multicenter cross-sectional study

    R. Morimoto, M. Iijima, Y. Okuma, K. Suzuki, F. Yoshii, S. Nogawa, T. Osada, K. Kitagawa (Tokyo, Japan)

    Objective: We aimed to investigate factors associated with non-motor symptoms (NMS) in Parkinson's disease (PD). Background: PD is characterized by a variety of NMS, such…
  • 2023 International Congress

    Efficacy of levodopa/carbidopa/entacapone replacement of levodopa/dopa decarboxylase inhibitors in treatment of Chinese Parkinson’s disease patients with wearing-off: a multicenter, randomized controlled, open label study

    CY. Yu, WG. Liu, AP. Gong, LH. Shen, H. Huang, Y. Zhao, CF. Liu (nanjing, China)

    Objective: This study aimed to investigate the efficacy and safety comparison between LCE and Pramexol in Chinese PD patients with the wearing-off phenomenon. Background: Wearing…
  • 2023 International Congress

    Analysis of the therapeutic potential of IkT-148009 in Parkinson’s disease

    M. Werner, R. Rush, T. Kelly, S. Singh, S. Kruger, C. Olanow, A. Mcgarry (Atlanta, USA)

    Objective: To evaluate the therapeutic potential of the selective, brain penetrant c-Abl inhibitor IkT-148009 in mouse models of progressive PD and the safety and tolerability…
  • 2023 International Congress

    Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

    Objective: The objective of our pilot study was to assess the feasibility of using a portable accelerometer system to accurately identify motor findings in patients…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley